|
End-of-day quote
Shanghai S.E.
2026-09-01
|
5-day change | 1st Jan Change | ||
| 10.47 CNY | +3.56% |
|
+3.25% | -3.15% |
| Market Cap | 5.93B 883M 761M 716M 652M 1.23B 83.76B 1.23B 8.47B 3.3B 42.61B 3.31B 3.24B 141B | P/E 2024 |
20.4x | P/E 2025 | 46.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.43B 808M 697M 655M 597M 1.12B 76.66B 1.13B 7.75B 3.02B 39B 3.03B 2.97B 129B | EV / Sales 2024 |
0.41x | EV / Sales 2025 | 0.56x |
| Free-Float |
24.73% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +3.56% | ||
| 1 week | +3.25% | ||
| Current month | +3.56% | ||
| 1 month | +13.31% | ||
| 3 months | +18.04% | ||
| 6 months | -4.47% | ||
| Current year | -3.15% |
| 1 week | 9.98 |  | 10.77 |
| 1 month | 9.1 | | 12.79 |
| Current year | 7.54 | | 13.16 |
| 1 year | 7.54 | | 18.13 |
| 3 years | 4.96 | | 18.13 |
| 5 years | 4.96 | | 18.13 |
| 10 years | 4.88 | | 18.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CEO | Chief Executive Officer | 57 | 2016-09-25 |
Ping Guan
DFI | Director of Finance/CFO | 54 | 2022-04-06 |
Rui Qu
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CHM | Chairman | 57 | 2023-12-14 |
Shi Wei Yin
BRD | Director/Board Member | 51 | 2023-12-25 |
Dan Guo
BRD | Director/Board Member | 56 | 2023-12-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.56% | +3.25% | +25.84% | +34.75% | 903M | |
| +1.76% | +2.57% | +32.98% | +125.90% | 106B | |
| +2.33% | +2.47% | +63.35% | +181.08% | 55.67B | |
| 0.00% | -4.58% | -12.30% | +243.04% | 22.3B | |
| +0.86% | +0.12% | -11.36% | -8.13% | 8.16B | |
| +0.44% | +0.37% | -39.76% | -28.23% | 7.14B | |
| +2.09% | +5.55% | +10.02% | +25.41% | 6.62B | |
| +0.42% | +1.52% | -2.45% | +20.82% | 5.1B | |
| +1.26% | +14.42% | +307.90% | +469.24% | 4.35B | |
| -0.60% | -0.26% | +10.00% | +14.31% | 3.75B | |
| Average | +1.26% | +1.42% | +38.42% | +107.82% | 21.97B | |
| Weighted average by Cap. | +1.58% | +0.13% | +35.57% | +140.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.05B 1.49B 1.29B 1.21B 1.11B 2.08B 142B 2.09B 14.34B 5.58B 72.17B 5.61B 5.49B 239B | 10.38B 1.54B 1.33B 1.25B 1.14B 2.15B 147B 2.16B 14.81B 5.77B 74.55B 5.8B 5.67B 247B |
| Net income | 213M 31.73M 27.37M 25.75M 23.46M 44.11M 3.01B 44.35M 304M 118M 1.53B 119M 117M 5.08B | 134M 19.91M 17.18M 16.16M 14.72M 27.68M 1.89B 27.83M 191M 74.35M 961M 74.76M 73.14M 3.19B |
| Net Debt | -200M -29.71M -25.63M -24.11M -21.96M -41.3M -2.82B -41.52M -285M -111M -1.43B -112M -109M -4.76B | -503M -74.84M -64.56M -60.73M -55.32M -104M -7.1B -105M -718M -279M -3.61B -281M -275M -11.98B |
Employees
2,735
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | CN¥10.23 | -2.29% | 14,438,730 |
| 26-09-01 | CN¥10.47 | +3.56% | 23,785,742 |
| 26-08-31 | CN¥10.11 | -1.94% | 19,342,300 |
| 26-08-28 | CN¥10.31 | -2.55% | 24,835,640 |
| 26-08-27 | CN¥10.58 | +3.93% | 43,376,438 |
- Stock Market
- Stocks
- 600829 Stock
Select your edition
All financial news and data tailored to specific country editions
